Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Connect Biopharma
Connect Biopharma
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
The Ides of March bring no misfortune to biotech, as industry logs second-busiest IPO week of 2021
Endpoints
IPOs
NASDAQ
Instil Bio
Connect Biopharma
Finch Therapeutics
Gain Therapeutics
Flag link:
Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street
Four IPOs and a SPAC pitch a new slate of microbiome, cancer and inflammatory drugs to Wall Street
Endpoints
IPOs
SPAC
Finch Therapeutics
microbiome
Connect Biopharma
Insil Bio
Transcode Therapeutics
Flag link:
Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators
Connect Biopharma snags $115 million in Series C to develop arsenal of immune modulators
Endpoints
Connect Biopharma
Series C
immune modulators
Flag link:
